tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
SNTI
Senti Biosciences
RESEARCH TOOLSreports

Senti Biosciences (SNTI) Financial Statements

245 Followers

Senti Biosciences Financial Overview

Senti Biosciences's market cap is currently $26.13M. The company's EPS TTM is $-0.53; its P/E ratio is -3.81; Senti Biosciences is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 22.00K$ 0.00$ 1.98M$ 3.29M$ 2.29M
Gross Profit$ -3.62M$ 0.00$ 1.98M$ 3.29M$ 2.29M
Operating Income$ -63.73M$ -61.04M$ -92.73M$ -62.08M$ -40.45M
EBITDA$ -60.09M$ -54.88M$ -61.34M$ -58.16M$ -37.44M
Net Income$ -61.44M$ -52.79M$ -71.06M$ -58.21M$ -55.32M
Balance Sheet
Cash & Short-Term Investments$ 16.42M$ 48.28M$ 35.93M$ 98.56M$ 56.03M
Total Assets$ 51.22M$ 97.84M$ 119.48M$ 180.79M$ 96.70M
Total Debt$ 28.89M$ 33.64M$ 37.67M$ 37.09M$ 22.73M
Net Debt$ 12.47M$ -14.64M$ 1.74M$ -20.53M$ -33.30M
Total Liabilities$ 45.63M$ 72.19M$ 52.57M$ 53.53M$ 36.33M
Stockholders' Equity$ 5.59M$ 25.65M$ 66.91M$ 127.26M$ 60.38M
Cash Flow
Free Cash Flow$ -43.64M$ -41.42M$ -64.43M$ -76.27M$ -40.18M
Operating Cash Flow$ -43.44M$ -41.40M$ -52.40M$ -34.90M$ -34.63M
Investing Cash Flow$ -184.00K$ 34.00K$ 30.08M$ -81.96M$ -5.54M
Financing Cash Flow$ 11.76M$ 53.73M$ 779.00K$ 118.55M$ 68.44M
Currency in USD

Senti Biosciences Earnings and Revenue History

Income Statement >

Senti Biosciences Debt to Assets

Balance Sheet >

Senti Biosciences Cash Flow

Cash Flow >

Senti Biosciences Forecast EPS vs Actual EPS

Earnings >